Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients

Expert Opinion on Pharmacotherapy

Volumn 12, Issue 16, 2011, Pages 2441-2448

  Fogari, Roberto ^a   Zoppi, Annalisa ^a   Maffioli, Pamela ^a   Lazzari, Pierangelo ^a   Mugellini, Amedeo ^a   Derosa, Giuseppe ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

amlodipine; ankle edema; hypertension; telmisartan

Indexed keywords

AMLODIPINE; NORADRENALIN; RENIN; TELMISARTAN;

ADULT; AGED; ANKLE EDEMA; ANKLE FOOT VOLUME; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NORADRENALIN BLOOD LEVEL; OUTPATIENT CARE; PRETIBIAL SUBCUTANEOUS TISSUE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT DURATION;

ADULT; AGED; AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANKLE; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; CROSS-OVER STUDIES; DRUG COMBINATIONS; EDEMA; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NOREPINEPHRINE;

EID: 80054076692     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2011.623698     Document Type: Article

References (36)

1. Weir MR. Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. J Clin Hypertens 2003;12:330-5
2. Sica DA. Pharmacotherapy review: calcium channel blockers. J Clin Hypertens 2006;8:53-6
3. Chrisant SG. Proactive compared with passive adverse event recognition: calcium channel blocker-associated edema. J Clin Hypertens 2008;10:716-22
4. Gustaffson D. Microvascular mechanisms involved in calcium antagonist edema formation. J Cardiovasc Pharmacol 1987;10(Suppl 1):S121-31
5. Messerli FH. Vasodilatory edema: a common side effect of antihypertensive therapy. Am J Hypertens 2001;14:978-9 (Pubitemid 32862603)
6. Gustaffsson D, Grande PE, Borgstrom P, Lindberg L. Effects of calcium antagonists on myogenic and neurogenic control of resistance and capacitance vessels in cat skeletal muscle. J Cardiovasc Pharmacol 1988;12:413-22
7. Salmasi AM, Belcaro G, Nicolaides AN. Impaired venoarteriolar reflex as a possible cause for nifedipine-induced ankle edema. Int J Cardiol 1991;30:303-7
8. Fogari R, Malamani GD, Zoppi A, et al. Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: a double-blind, randomized, parallel group study. Curr Ther Res Clin Exp 2000;61:850-62 (Pubitemid 32015352)
9. Fogari R, Mugellini A, Zoppi A, et al. Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. Am J Hypertens 2003;16:596-9 (Pubitemid 36829711)
10. Fogari R. Ankle edema and sympathetic activation. Drugs 2005;65(Suppl 2):21-7
11. Weir M, Rosenberg C, Fink JC. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE-inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. Am J Hypertens 2001;14:963-8 (Pubitemid 32862599)
12. Guazzi MD, De Cesare N, Galli C, et al. Calcium channel blockade with nifedipine and angiotensin converting enzyme with captopril in the therapy of patients with severe primary hypertension. Circulation 1984;70:279-84 (Pubitemid 14053050)
13. Messerli FH, Oparil S, Feng Z. Comparison of the efficacy and side-effects of combination therapy of angiotensin converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol 2000;86:1182-7
14. Pedrinelli R, Dell'Olmo G, Melillo E, Mariani M. Amlodipine, enalapril and dependent leg edema in essential hypertension. Hypertension 2000;35:621-5 (Pubitemid 30108158)
15. Fogari R, Malamani GD, Zoppi A, et al. Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2003;17:207-12 (Pubitemid 36388805)
16. Fogari R, Malamani GD, Zoppi A, et al. Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study. Clin Ther 2007;29:413-18 (Pubitemid 46907281)
17. Philipp T, Smith TR, Glazer R, et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007;29:563-80 (Pubitemid 47028551)
18. Fogari R, Zoppi A, Derosa G, et al. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2007;21:220-4
19. De la Sierra A. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system. J Hum Hypertens 2009;23:503-11
20. Fogari R, Malamani GD, Corradi L, et al. Effect of valsartan or olmesartan addition to amlodipine on ankle oedema in hypertensive patients. Adv Ther 2010;27:48-55
21. Tabizchi R, King KA, Pang CC. Direct and indirect effects of angiotensin II on venous tone in conscious rats. Eur J Pharmacol 1992;219:141-5
22. Fernandes L, Loiola RA, Tostes RCA, et al. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide. Peptides 2005;26:2458-63 (Pubitemid 41676717)
23. Rea RF, Eckberg DL, Fritsch JM, Goldstein DS. Relation of plasma norepinephrine and sympathetic traffic during hypertension in humans. Am J Physiol 1990;258:R982-6 (Pubitemid 20155599)
24. Abdelrahman AM, Burrel LM, Johnston CI. Blockade of the renin-angiotensin system at different sites: effect of renin, angiotensin and aldosterone. J Hypertens 1993;11(Suppl 3):S49-52
25. Hansson L, Hedner T, Dahlof B. Prospective, Randomized, Open, Blinded End point (PROBE) study: a novel design for intervention trials. Blood Press 1992;1:113-14
26. Lauderer A. Die Gewebspannung in ihren Einfluss anf die Ortliche Blut-vud Lymphbewegung. Fogel FCW; Leipzig: 1884. p. 174
27. Burch GE, Sodeman WA. The estimation of subcutaneous pressure by direct method. J Clin Invest 1937;16:845-50
28. Malamani V. Modificazioni della pressione dei tessuti nell'edema provocato. Boll Soc Ital Biol Sper 1947;23:125-31
29. Malamani V. La pressione nei tessuti. Tipografia Popolare; Pavia: 1957. p. 485
30. Remie R, Zaagsma J. A new tecnique for the study of vascular presynaptic receptors in freely moving rats. Heart Circ Physiol 1986;251:4463-7
31. Hjemdahl P. Plasma catecholamines as markers for sympathoadrenal activity in human primary hypertension. Pharmacol Toxicol 1988;63(Suppl 1):S27-31
32. Nussberger J, Fasanella d'Amore T, Porchet M, et al. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol 1987;9:39-44 (Pubitemid 17212750)
33. Fogari R, Preti P, Zoppi A, et al. Effect of telmisartan/ hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. Am J Hypertens 2005;18:577-83 (Pubitemid 40692422)
34. Dendorfer A, Raasch W, Tempel K, Dominiak P. Interaction between the renin-angiotensin system (RAS) and the sympathetic system. Basic Res Cardiol 1998;93:24-9 (Pubitemid 28498126)
35. Balt JC, Mathy MJ, Pfaffendorf M, Van Zwieten PA. Sympathoinhibitory properties of various AT1 receptor antagonists. J Hypertens 2002;20(Suppl 5):S3-11 (Pubitemid 34925654)
36. Ye S, Zhong H, Duong N, Campese VM. Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 2002;39:1101-6 (Pubitemid 34620131)